Literature DB >> 6118522

Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980.

M Reacher, C C Campbell, J Freeman, E B Doberstyn, A D Brandling-Bennett.   

Abstract

A trial of drug regimens for treating Plasmodium falciparum malaria was conducted in a refugee camp in eastern Thailand where extensive 'Fansidar' (pyrimethamine-sulfadoxine) resistance had been demonstrated. The efficacy of quinine alone was compared to that of quinine combined with either fansidar or tetracycline. Quinine alone cleared the parasitaemia in 57 of 59 patients but failed to cure approximately one-third of these patients after 7 or 10 days of therapy. The addition of fansidar to quinine therapy did not significantly improve the overall cure rate. Tetracycline given for 10 days in combination with quinine cured all patients, suggesting that tetracycline should be considered in treating patients with falciparum malaria contracted in the area of the Thai-Kampuchean border.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6118522     DOI: 10.1016/s0140-6736(81)91274-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Antimalarial agents: specific treatment regimens.

Authors:  D J Krogstad; B L Herwaldt; P H Schlesinger
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 2.  Resistance of Plasmodium falciparum.

Authors:  E B Doberstyn
Journal:  Experientia       Date:  1984-12-15

3.  Drug resistance in malaria: three cases and a review.

Authors:  J L Isaac-Renton; A L Koon; R M Chan; A W Chow; S L Sacks
Journal:  Can Med Assoc J       Date:  1983-09-01       Impact factor: 8.262

4.  Clones of different sensitivities in drug-resistant isolates of Plasmodium falciparum.

Authors:  S Thaithong
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

5.  An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81.

Authors:  S Pinichpongse; E B Doberstyn; J R Cullen; L Yisunsri; Y Thongsombun; K Thimasarn
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

6.  Falciparum malaria resistant to chloroquine and Fansidar: implications for prophylaxis.

Authors:  S J Eyre
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-25

7.  Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria.

Authors:  S Pukrittayakamee; A Chantra; S Vanijanonta; R Clemens; S Looareesuwan; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 8.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Quinine dosage in severe malaria with renal failure necessitating haemodialysis.

Authors:  A M Sharma; F Keller; M Boeckh; J Heitz; K Borner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

10.  Chloroquine-resistant falciparum malaria imported into the Netherlands.

Authors:  J C Wetsteyn; A de Geus
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.